1. Home
  2. IMMP vs PCYO Comparison

IMMP vs PCYO Comparison

Compare IMMP & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • PCYO
  • Stock Information
  • Founded
  • IMMP 1987
  • PCYO 1976
  • Country
  • IMMP Australia
  • PCYO United States
  • Employees
  • IMMP N/A
  • PCYO N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • PCYO Water Supply
  • Sector
  • IMMP Health Care
  • PCYO Utilities
  • Exchange
  • IMMP Nasdaq
  • PCYO Nasdaq
  • Market Cap
  • IMMP 264.7M
  • PCYO 307.4M
  • IPO Year
  • IMMP N/A
  • PCYO N/A
  • Fundamental
  • Price
  • IMMP $2.05
  • PCYO $12.76
  • Analyst Decision
  • IMMP Buy
  • PCYO
  • Analyst Count
  • IMMP 2
  • PCYO 0
  • Target Price
  • IMMP $8.50
  • PCYO N/A
  • AVG Volume (30 Days)
  • IMMP 106.2K
  • PCYO 43.3K
  • Earning Date
  • IMMP 11-26-2024
  • PCYO 11-13-2024
  • Dividend Yield
  • IMMP N/A
  • PCYO N/A
  • EPS Growth
  • IMMP N/A
  • PCYO 152.63
  • EPS
  • IMMP N/A
  • PCYO 0.48
  • Revenue
  • IMMP $2,563,302.00
  • PCYO $28,747,000.00
  • Revenue This Year
  • IMMP N/A
  • PCYO N/A
  • Revenue Next Year
  • IMMP $10.84
  • PCYO N/A
  • P/E Ratio
  • IMMP N/A
  • PCYO $26.58
  • Revenue Growth
  • IMMP 9.59
  • PCYO 97.09
  • 52 Week Low
  • IMMP $1.58
  • PCYO $8.94
  • 52 Week High
  • IMMP $3.34
  • PCYO $13.40
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 55.82
  • PCYO 69.09
  • Support Level
  • IMMP $1.85
  • PCYO $11.50
  • Resistance Level
  • IMMP $2.06
  • PCYO $13.40
  • Average True Range (ATR)
  • IMMP 0.10
  • PCYO 0.51
  • MACD
  • IMMP 0.03
  • PCYO 0.15
  • Stochastic Oscillator
  • IMMP 70.89
  • PCYO 78.31

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. It designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The company's services include water production, storage, treatment, bulk transmission to retail distribution systems, wastewater collection and treatment, irrigation water treatment and transmission, construction management, billing, and collection. The land resource development segment includes all the activities necessary to develop and sell finished lots.

Share on Social Networks: